Korea Biopharma Excellence Awards
The Korea Biopharma Excellence Awards celebrate the achievements of biopharma experts/organizations in South Korea and East Asia who have made remarkable advancements in biologics, cell and gene therapy, and vaccine development throughout the years. This year, the ceremony is held in conjunction with the highly anticipated 13th Biologics Manufacturing Korea and 6th Vaccine World East Asia conferences.
Korea Biopharma Excellence Awards 2024
The Korea Biopharma Excellence Awards seeks to recognize exceptional biopharma experts, organizations, and technologies that drive excellence in biopharmaceutical development and manufacturing. This prestigious accolade celebrates exemplary leaders and trend-setters across the biopharmaceutical sectors, showcasing the latest technological advancements and best practices in the industry.
The Awards ceremony will coincide with the 13th Biologics Manufacturing Korea and 6th Vaccine World East Asia, uniting over 300 representatives from South Korea’s top biopharmaceutical companies and leading organizations across East Asia.
Vote for an organization/individual now till 31st May:
Important event information
Korea Biopharma Excellence Awards 2024
5:15 PM KST
13th August 2024
Incheon Songdo Convention Center, South Korea
Form valuable connections with established biopharma companies in Korea and East Asia.
Gain unique insights from Awards Winners in order to build your own company’s efforts in the biopharma space
Enjoy cocktails and dinner while networking in a relaxed atmosphere.
KBEA 2024 Categories
- Best Bioprocessing Supplier Award: Upstream Processing
- Best Bioprocessing Supplier Award: Downstream Processing
- Best Bioprocessing Supplier Award: Bioreactors
- Best Bioprocessing Supplier Award: Chromatography
- Best Bioprocessing Supplier Award: Filtration & Purification
- Best Bioprocessing Supplier Award:
- Fill Finish
- Best Bioprocessing Supplier Award: Engineering & Facility Design
- Best Bioprocessing Supplier Award: Automation
- Best Bioprocessing Supplier Award: Single Use Systems
- Best Bioprocessing Supplier Award: Continuous Bioprocessing
- Best New Bioprocessing Facility Design
- Biopharma Innovation of the Year
- Overall Biopharma Supplier of the Year
- Best CDMO Award
- Best CRO Award
- Best Biologics CMO Award
- Bioprocessing Excellence in mRNA Manufacturing
- Bioprocessing Excellence in Cell & Gene Therapy Manufacturing
- Bioprocessing Excellence in Vaccine Manufacturing
Best Fill-Finish CMO Award
- Best Temperature Control Packaging Provider
- Best Temperature Monitoring Solution Provider
- Best Last Mile Implementation
- Innovation in Clinical Supply Chain Logistics
- Vaccine Cold Chain Storage Management Excellence
- Most Promising Biologics Drug Pipeline
- Most Promising Cell & Gene Therapy Pipeline
- Most Promising Vaccine for Epidemic
- Most Promising Therapeutic Vaccine
- Most Promising Early Stage Biopharma
- Most Promising New Vaccine Technology
- Most Promising Academic/Research Team
- Lifetime Achievement Award
How does it work?
IMAPAC, the organizing committee of KBEA 2024, will invite nominations from the South Korea and East Asia biopharma communities for various award categories. All entries and nominations will be carefully evaluated and submitted to the judging panel for review.
Following thorough assessment and consideration of the number of nominations, the top entries in each category will be shortlisted. The award winners will be determined based on the results of over 10000 votes from the South Korea and East Asia biopharma communities.
TIMELINE OF AWARDS
KBEA 2024 Media Partner
AWARDS CRITERIA
The criteria for a company to be eligible for the Korea Biopharma Excellence Awards (KBEA) 2024 are:
- The company should be an organization involved in the development and/or manufacturing of biologics, cell and gene therapy and vaccines
- The company should have a notable presence in South Korea or East Asia
- The company should have displayed significant developments in the past few years
Based on the number of nominations and assessment, the top 5-7 entries under each category will be shortlisted. From the top 5-7 entries, the award winner will be determined by 100% voting results from the Biologics, Vaccine, and Cell and Gene Therapy Manufacturing community. Companies with the most number of votes will win the award in their respective category.
WHAT CAN YOU EXPECT?
CHOOSE YOUR PLAN
Select the Ticketing Option That Fits Your Needs
BOOK A TABLE
Our award can boost your company’s recognition and reputation, portraying innovation and adaptability. The awards give you the opportunity to showcase your technologies and get recognised for your achievements. We recognise and value outstanding achievements and technologies made by experts in the industry.
